相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
Z. Ping Lin et al.
SCIENTIFIC REPORTS (2021)
CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential
Juanni Li et al.
ONCOGENE (2020)
Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells
Nongyao Nonpanya et al.
ANTICANCER RESEARCH (2020)
p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
Yang Yang-Hartwich et al.
MOLECULAR CANCER RESEARCH (2019)
The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
Cai M. Roberts et al.
CANCERS (2019)
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer
Z. Ping Lin et al.
PLOS ONE (2018)
Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
Paola Francica et al.
GENOME MEDICINE (2018)
Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance
Katsutoshi Oda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models
Cai M. Roberts et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2017)
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
Margaret E. Whicker et al.
BMC CANCER (2016)
Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair
Elena S. Ratner et al.
BRITISH JOURNAL OF CANCER (2016)
TGF-β Pathway Inhibition Signals New Hope for Fanconi Anemia
Hemanth Tummala et al.
CELL STEM CELL (2016)
TGF-β Signaling in Cancer
Viqar Syed
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
DNA repair targeted therapy: The past or future of cancer treatment?
Navnath S. Gavande et al.
PHARMACOLOGY & THERAPEUTICS (2016)
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
Cai M. Roberts et al.
SCIENTIFIC REPORTS (2016)
TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer
Chun-Te Wu et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance
Hyeonseok Ko
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
TGF-β1 mediates the radiation response of prostate cancer
Chun-Te Wu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Triapine Disrupts CtIP-Mediated Homologous Recombination Repair and Sensitizes Ovarian Cancer Cells to PARP and Topoisomerase Inhibitors
Z. Ping Lin et al.
MOLECULAR CANCER RESEARCH (2014)
TGFβ Induces BRCAness and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes
Liang Liu et al.
MOLECULAR CANCER RESEARCH (2014)
Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential
G. Yin et al.
ONCOGENE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Repair of Double-Strand Breaks by End Joining
Kishore K. Chiruvella et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
Vinicius Craveiro et al.
CANCER MEDICINE (2013)
Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer
Elena S. Ratner et al.
CURRENT OPINION IN ONCOLOGY (2012)
Epithelial-mesenchymal transitions: insights from development
Jormay Lim et al.
DEVELOPMENT (2012)
Complexities of TGF-β Targeted Cancer Therapy
Erin C. Connolly et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
Joanne M. Munck et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression
Zhao-Qiu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761
Erin C. Connolly et al.
CANCER RESEARCH (2011)
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
Dejuan Kong et al.
Cancers (2011)
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
Karina Dahl Steffensen et al.
JOURNAL OF ONCOLOGY (2011)
The epithelial-mesenchymal transition (EMT) phenomenon
P. Savagner
ANNALS OF ONCOLOGY (2010)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
Farhad Vesuna et al.
NEOPLASIA (2009)
Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer
S. Kyle et al.
BRITISH JOURNAL OF RADIOLOGY (2008)
Transforming growth factor-β signaling in cancer invasion and metastasis
Suvi-Katri Leivonen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma
Mikio Terauchi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Inhibition of transforming growth factor-β1 signaling attenuates ataxia telanglectasia mutated activity in response to genotoxic stress
Julia Kirshner et al.
CANCER RESEARCH (2006)
A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer
Simone Spaderna et al.
GASTROENTEROLOGY (2006)
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter
KE Bachman et al.
CURRENT OPINION IN ONCOLOGY (2005)
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries
JJJ Leahy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
分享论文
